TCL Archive NCI Invites “Extraordinary Opportunities” For Research. Groups Planning Promotion Of Cancer Clinical Trials. May 4, 2001
TCL Archive DeVita’s “Radical” Statement – Resectability Rate Should Be The Cure Rate October 1, 1976
TCL Archive Vaccine and LDCT Pretreatment Can Help PDACs Become Vulnerable to Immunotherapy June 27, 2014